118 related articles for article (PubMed ID: 6885552)
1. Systemic, bladder wall, and bladder tumor concentration of misonidazole following intravesical administration in the rat.
Fathi MA; Fisher GJ; Pageau R; Tahan TW; Nigam VN; Brailovsky CA; Elhilali MM
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1397-400. PubMed ID: 6885552
[TBL] [Abstract][Full Text] [Related]
2. Intravesical administration of misonidazole in bladder carcinoma.
Ghoneim MA; Shaaban AA; El-Merzabani MM; Awaad HK; El Gammal S
Acta Radiol Oncol; 1983; 22(3):177-81. PubMed ID: 6312756
[TBL] [Abstract][Full Text] [Related]
3. The topical use of misonidazole in bladder cancer.
Awwad HK; Abd El Moneim H; Abd El Baki H; Omar S; El Merzabani M; Farag HI
Prog Clin Biol Res; 1983; 132D():305-16. PubMed ID: 6634802
[TBL] [Abstract][Full Text] [Related]
4. Anal submucosal injection: a new route for drug administration in pelvic malignancies. Part I. Experimental study of misonidazole distribution in serum and tissues, with special reference to urinary bladder. Preliminary report.
Shafik A; el-Merzabani MM; el-Aaser AA; el-Desouky GH
Invest Radiol; 1986 Mar; 21(3):278-81. PubMed ID: 3957602
[TBL] [Abstract][Full Text] [Related]
5. Penetration of misonidazole after intravesical administration in cases of carcinoma of the bilharzial bladder.
Awwad HK; el-Merzabani MM; Burgers MV
Br J Cancer Suppl; 1978 Jun; 3():297-8. PubMed ID: 277248
[TBL] [Abstract][Full Text] [Related]
6. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
Chin JB; Rauth AM
Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
[No Abstract] [Full Text] [Related]
7. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
Garrecht BM; Chapman JD
Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
[TBL] [Abstract][Full Text] [Related]
8. Distribution of misonidazole in human tumours and normal tissues.
Ash DV; Smith MR; Bugden RD
Br J Cancer; 1979 May; 39(5):503-9. PubMed ID: 486305
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
11. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
Akel G; Canal P; Bugat R; Soula G; Combes PF
J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
13. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity.
See WA; Xia Q
J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441
[TBL] [Abstract][Full Text] [Related]
14. Polarographic measurement of misonidazole in mouse mammary tumors.
Ohizumi Y; Maezawa H; Murayama C; Mori T
Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
[TBL] [Abstract][Full Text] [Related]
15. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
Masuda H; Hirai M; Ohtawara Y; Tajima A; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
[TBL] [Abstract][Full Text] [Related]
16. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
[TBL] [Abstract][Full Text] [Related]
17. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
[TBL] [Abstract][Full Text] [Related]
18. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
Smith BR; Born JL; Garcia DJ
Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
[TBL] [Abstract][Full Text] [Related]
19. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
Shoemaker D; Upton D; Strong J
Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
[TBL] [Abstract][Full Text] [Related]
20. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
